Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;38(4):282-286.
doi: 10.3857/roj.2020.00577. Epub 2020 Dec 2.

Primary intracranial leiomyosarcoma presenting with frontal bone mass: a case report

Affiliations
Case Reports

Primary intracranial leiomyosarcoma presenting with frontal bone mass: a case report

Shaghayegh Kamian et al. Radiat Oncol J. 2020 Dec.

Abstract

Primary intracranial mesenchymal neoplasms are rare tumors. These tumors are usually metastatic disease from other primary sites. We presented a 31-year-old man with a 6-month history of gradually enlarging frontal mass and positional headache. There was no other symptom demonstrating other organs' involvement. The patient underwent an uncomplicated craniotomy with clear surgical margins. The pathology review and the immunohistochemistry staining confirmed leiomyosarcoma grade II. We prescribed radiation therapy with tumor dose of 60 Gy in 30 fractions with conformal treatment planning to the tumor bed. As this disease has a high potency for metastasis, we advised four courses of single agent doxorubicin chemotherapy 75 mg/m2 every 4 weeks starting one month after the end of radiotherapy. In the last follow-up visit 34 months later, the patient was disease free in physical exam and imaging findings.

Keywords: Brain neoplasms; Intracranial; Leiomyosarcoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
An axial view of brain magnetic resonance imaging.
Fig. 2.
Fig. 2.
Immunohistochemistry staining showing h-caldesmon positivity (microscopic image at ×40).
Fig. 3.
Fig. 3.
Interlacing bundles of spindle to oval cells with moderate dysplasia and noticeable mitotic figures (microscopic image at ×40).
Fig. 4.
Fig. 4.
Immunohistochemistry staining showing vimentin positivity (microscopic image at ×40).
Fig. 5.
Fig. 5.
Target volumes (GTV in red and PTV in blue) and isodoses around target volume (isodose 95% in green and 90% in yellow with maximum hot dose of 105% in the GTV). GTV, gross tumor volume; PTV, planning target volume.

Similar articles

Cited by

References

    1. Torihashi K, Chin M, Yoshida K, Narumi O, Yamagata S. Primary intracranial leiomyosarcoma with intratumoral hemorrhage: case report and review of literature. World Neurosurg. 2018;116:169–73. - PubMed
    1. Li XL, Ren J, Niu RN, et al. Primary intracranial leiomyosarcoma in an immunocompetent patient: case report with emphasis on imaging features. Medicine (Baltimore) 2019;98:e15269. - PMC - PubMed
    1. Saito A, Ninomiya A, Ishida T, et al. Intractable repeated intracerebral hemorrhage due to primary dural leiomyosarcoma: case report and literature review. World Neurosurg. 2019;122:116–22. - PubMed
    1. Bregy A, Lim J, Lohman R, et al. Primary leiomyosarcoma of the calvarium with intracranial extension: a case report. Indian J Surg Oncol. 2020 Jul 1; doi: 10.1007/s13193-020-01129-z. [Epub]. - DOI - PMC - PubMed
    1. Morales RL, Alvarez A, Norena MP, Torres F, Esguerra J. Low-grade leiomyosarcoma of the cavernous sinus in an HIV positive patient: case report. Cureus. 2020;12:e6758. - PMC - PubMed

Publication types